Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Junctophilin-2 expression rescues atrial dysfunction through polyadic junctional membrane complex biogenesis
Sören Brandenburg, Jan Pawlowitz, Benjamin Eikenbusch, Jonas Peper, Tobias Kohl, Gyuzel Y. Mitronova, Samuel Sossalla, Gerd Hasenfuss, Xander H.T. Wehrens, Peter Kohl, Eva A. Rog-Zielinska, Stephan E. Lehnart
Sören Brandenburg, Jan Pawlowitz, Benjamin Eikenbusch, Jonas Peper, Tobias Kohl, Gyuzel Y. Mitronova, Samuel Sossalla, Gerd Hasenfuss, Xander H.T. Wehrens, Peter Kohl, Eva A. Rog-Zielinska, Stephan E. Lehnart
View: Text | PDF
Research Article Cardiology Cell biology

Junctophilin-2 expression rescues atrial dysfunction through polyadic junctional membrane complex biogenesis

  • Text
  • PDF
Abstract

Atrial dysfunction is highly prevalent and associated with increased severity of heart failure. While rapid excitation-contraction coupling depends on axial junctions in atrial myocytes, the molecular basis of atrial loss of function remains unclear. We identified approximately 5-fold lower junctophilin-2 levels in atrial compared with ventricular tissue in mouse and human hearts. In atrial myocytes, this resulted in subcellular expression of large junctophilin-2 clusters at axial junctions, together with highly phosphorylated ryanodine receptor (RyR2) channels. To investigate the contribution of junctophilin-2 to atrial pathology in adult hearts, we developed a cardiomyocyte-selective junctophilin-2–knockdown model with 0 mortality. Junctophilin-2 knockdown in mice disrupted atrial RyR2 clustering and contractility without hypertrophy or interstitial fibrosis. In contrast, aortic pressure overload resulted in left atrial hypertrophy with decreased junctophilin-2 and RyR2 expression, disrupted axial junctions, and atrial fibrosis. Whereas pressure overload accrued atrial dysfunction and heart failure with 40% mortality, additional junctophilin-2 knockdown greatly exacerbated atrial dysfunction with 100% mortality. Strikingly, transgenic junctophilin-2 overexpression restored atrial contractility and survival through de novo biogenesis of polyadic junctional membrane complexes maintained after pressure overload. Our data show a central role of junctophilin-2 cluster disruption in atrial hypertrophy and identify transgenic augmentation of junctophilin-2 as a disease-mitigating rationale to improve atrial dysfunction and prevent heart failure deterioration.

Authors

Sören Brandenburg, Jan Pawlowitz, Benjamin Eikenbusch, Jonas Peper, Tobias Kohl, Gyuzel Y. Mitronova, Samuel Sossalla, Gerd Hasenfuss, Xander H.T. Wehrens, Peter Kohl, Eva A. Rog-Zielinska, Stephan E. Lehnart

×

Figure 3

Left atrial junctophilin-2 cluster dispersion, RyR2 cluster decrease, and AT proliferation in aortic pressure overload.

Options: View larger image (or click on image) Download as PowerPoint
Left atrial junctophilin-2 cluster dispersion, RyR2 cluster decrease, an...
(A) Immunoblots show reduced left atrial expression of junctophilin-2 (JP2), RyR2, and caveolin-3 4 weeks after TAC. Data represent 3 independent experiments each for sham and TAC. (B–D) Dual-color STED immunofluorescence imaging of isolated left AMs 4 weeks after TAC labeled for JP2, caveolin-3, RyR2, and phospho-epitope specific RyR2-pSer2808. (B) Caveolin-3–positive axial tubules increase in number after TAC, and junctional JP2 clusters appear dispersed at axial tubules. (C) JP2 colocalization with RyR2 is decreased after TAC. (D) Highly phosphorylated RyR2-pS2808 clusters decrease in size after TAC. Dashed boxes indicate magnified views on the right. Scale bar: 1 μm. (E–H) Analysis of segmented STED images. RyR2 area fraction (E) and RyR2 cluster density (F) were significantly decreased after TAC. (G) TAC induced a significant increase in percentage overlap of RyR2 with JP2 clusters, while percentage overlap of JP2 with RyR2 clusters was decreased. (H) The areas of overlapping JP2 and RyR2 clusters were statistically unchanged after TAC. n = 3 individual hearts each; 17 sham and 13 TAC AM cells. (I) ET 3D reconstruction of cross-sectioned AT structures (green) and AT-SR junctions (red, ≤15 nm in gap width filled with RyR2 densities). Scale bar: 200 nm. (J) AT-SR junction length and the proportion of AT-SR junction area relative to the AT surface are significantly reduced after TAC. n = 3 individual hearts each. *P < 0.05; **P < 0.01; ***P < 0.001, Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts